Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Recombinant Coagulation Factors Industry 2016 Deep Market Research Report

  • QYR384784
  • 138 Pages
  • January 2016
  • Healthcare
Download Sample    Get Discount   
 
The United States Recombinant Coagulation Factors Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the Recombinant Coagulation Factors industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Coagulation Factors market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Coagulation Factors industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 142 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

1 Industry Overview

1.1 Definition and Specifications of Recombinant Coagulation Factors

1.2 Classification of Recombinant Coagulation Factors

1.3 Applications of Recombinant Coagulation Factors

1.4 Industry Chain Structure of Recombinant Coagulation Factors

1.5 Industry Overview of Recombinant Coagulation Factors

1.6 Industry Policy Analysis of Recombinant Coagulation Factors

1.7 Industry News Analysis of Recombinant Coagulation Factors

2 Manufacturing Cost Structure Analysis of Recombinant Coagulation Factors

2.1 Bill of Materials (BOM) of Recombinant Coagulation Factors

2.2 BOM Price Analysis of Recombinant Coagulation Factors

2.3 Labor Cost Analysis of Recombinant Coagulation Factors

2.4 Depreciation Cost Analysis of Recombinant Coagulation Factors

2.5 Manufacturing Cost Structure Analysis of Recombinant Coagulation Factors

2.6 Manufacturing Process Analysis of Recombinant Coagulation Factors

2.7 United States Price, Cost and Gross of Recombinant Coagulation Factors 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Recombinant Coagulation Factors Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Recombinant Coagulation Factors Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Recombinant Coagulation Factors Key Manufacturers in 2015

4 Production Analysis of Recombinant Coagulation Factors by Regions, Type, and Applications

4.1 United States Production of Recombinant Coagulation Factors by Regions 2011-2016

4.2 United States Production of Recombinant Coagulation Factors by Type 2011-2016

4.3 United States Sales of Recombinant Coagulation Factors by Applications 2011-2016

4.4 Price Analysis of United States Recombinant Coagulation Factors Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Recombinant Coagulation Factors 2011-2016

5 Consumption Volume and Consumption Value Analysis of Recombinant Coagulation Factors by Regions

5.1 United States Consumption Volume of Recombinant Coagulation Factors by Regions 2011-2016

5.2 United States Consumption Value of Recombinant Coagulation Factors by Regions 2011-2016

5.3 United States Consumption Price Analysis of Recombinant Coagulation Factors by Regions 2011-2016

6 Analysis of Recombinant Coagulation Factors Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Recombinant Coagulation Factors 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Recombinant Coagulation Factors 2014-2015

6.3 Sales Overview of Recombinant Coagulation Factors 2011-2016

6.4 Supply, Consumption and Gap of Recombinant Coagulation Factors 2011-2016

6.5 Import, Export and Consumption of Recombinant Coagulation Factors 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Recombinant Coagulation Factors 2011-2016

7 Analysis of Recombinant Coagulation Factors Industry Key Manufacturers

7.1 Baxter International Inc

7.1.1 Company Profile

7.1.2 Product Picture and Specification

7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.1.4 Baxter International Inc SWOT Analysis

7.2 Bayer AG

7.2.1 Company Profile

7.2.2 Product Picture and Specification

7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.2.4 Bayer AG SWOT Analysis

7.3 Biogen Idec

7.3.1 Company Profile

7.3.2 Product Picture and Specification

7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.3.4 Biogen Idec SWOT Analysis

7.4 CSL Ltd.

7.4.1 Company Profile

7.4.2 Product Picture and Specification

7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.4.4 CSL Ltd. SWOT Analysis

7.5 Grifols International SA

7.5.1 Company Profile

7.5.2 Product Picture and Specification

7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.5.4 Grifols International SA SWOT Analysis

7.6 Kedrion S.P.A.

7.6.1 Company Profile

7.6.2 Product Picture and Specification

7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.6.4 Kedrion S.P.A. SWOT Analysis

7.7 Novo Nordisk A/S

7.7.1 Company Profile

7.7.2 Product Picture and Specification

7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.7.4 Novo Nordisk A/S SWOT Analysis

7.8 Octapharma AG

7.8.1 Company Profile

7.8.2 Product Picture and Specification

7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.8.4 Octapharma AG SWOT Analysis

7.9 Pfizer Inc.

7.9.1 Company Profile

7.9.2 Product Picture and Specification

7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.9.4 Pfizer Inc. SWOT Analysis

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Recombinant Coagulation Factors Product Types

8.5 Market Share Analysis of Different Recombinant Coagulation Factors Price Levels

8.6 Gross Margin Analysis of Different Recombinant Coagulation Factors Applications

9 Marketing Trader or Distributor Analysis of Recombinant Coagulation Factors

9.1 Marketing Channels Status of Recombinant Coagulation Factors

9.2 Traders or Distributors of Recombinant Coagulation Factors with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Recombinant Coagulation Factors

9.4 United States Import, Export and Trade Analysis of Recombinant Coagulation Factors

10 Development Trend of Recombinant Coagulation Factors Industry 2016-2021

10.1 Capacity and Production Overview of Recombinant Coagulation Factors 2016-2021

10.2 Production Market Share by Product Types of Recombinant Coagulation Factors 2016-2021

10.3 Sales and Sales Revenue Overview of Recombinant Coagulation Factors 2016-2021

10.4 United States Sales of Recombinant Coagulation Factors by Applications 2016-2021

10.5 Import, Export and Consumption of Recombinant Coagulation Factors 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Recombinant Coagulation Factors 2016-2021

11 Industry Chain Suppliers of Recombinant Coagulation Factors with Contact Information

11.1 Major Raw Materials Suppliers of Recombinant Coagulation Factors with Contact Information

11.2 Manufacturing Equipment Suppliers of Recombinant Coagulation Factors with Contact Information

11.3 Major Players of Recombinant Coagulation Factors with Contact Information

11.4 Key Consumers of Recombinant Coagulation Factors with Contact Information

11.5 Supply Chain Relationship Analysis of Recombinant Coagulation Factors

12 New Project Investment Feasibility Analysis of Recombinant Coagulation Factors

12.1 New Project SWOT Analysis of Recombinant Coagulation Factors

12.2 New Project Investment Feasibility Analysis of Recombinant Coagulation Factors

13 Conclusion of the United States Recombinant Coagulation Factors Industry 2016 Deep Market Research Report


List Of Tables and Figures

Figure Picture of Recombinant Coagulation Factors

Table Product Specifications of Recombinant Coagulation Factors

Table Classification of Recombinant Coagulation Factors

Figure United States Sales Market Share of Recombinant Coagulation Factors by Product Types in 2015

Table Applications of Recombinant Coagulation Factors

Figure United States Sales Market Share of Recombinant Coagulation Factors by Applications in 2015

Figure Industry Chain Structure of Recombinant Coagulation Factors

Table United States Industry Overview of Recombinant Coagulation Factors

Table Industry Policy of Recombinant Coagulation Factors

Table Industry News List of Recombinant Coagulation Factors

Table Bill of Materials (BOM) of Recombinant Coagulation Factors

Table Bill of Materials (BOM) Price of Recombinant Coagulation Factors

Table Labor Cost of Recombinant Coagulation Factors

Table Depreciation Cost of Recombinant Coagulation Factors

Table Manufacturing Cost Structure Analysis of Recombinant Coagulation Factors in 2015

Figure Manufacturing Process Analysis of Recombinant Coagulation Factors

Table United States Price Analysis of Recombinant Coagulation Factors 2011-2016 (USD/Unit)

Table United States Cost Analysis of Recombinant Coagulation Factors 2011-2016 (USD/Unit)

Table United States Gross Analysis of Recombinant Coagulation Factors 2011-2016

Table Capacity (K Units) and Commercial Production Date of United States Recombinant Coagulation Factors Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Recombinant Coagulation Factors Manufacturers in 2015

Table R&D Status and Technology Source of United States Recombinant Coagulation Factors Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Recombinant Coagulation Factors Key Manufacturers in 2015

Table United States Production of Recombinant Coagulation Factors by Regions 2011-2016 (K Units)

Table United States Production Market Share of Recombinant Coagulation Factors by Regions 2011-2016

Figure United States Production Market Share of Recombinant Coagulation Factors by Regions in 2014

Figure United States Production Market Share of Recombinant Coagulation Factors by Regions in 2015

Table United States Production of Recombinant Coagulation Factors by Types in 2011-2016 (K Units)

Table United States Production Market Share of Recombinant Coagulation Factors by Type in 2011-2016

Figure United States Production Market Share of Recombinant Coagulation Factors by Type in 2014

Figure United States Production Market Share of Recombinant Coagulation Factors by Type in 2015

Table United States Sales of Recombinant Coagulation Factors by Applications 2011-2016 (K Units)

Table United States Production Market Share of Recombinant Coagulation Factors by Applications 2011-2016

Figure United States Production Market Share of Recombinant Coagulation Factors by Applications in 2014

Figure United States Production Market Share of Recombinant Coagulation Factors by Applications in 2015

Table Price Comparison of United States Recombinant Coagulation Factors Key Manufacturers in 2015 (USD/Unit)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Recombinant Coagulation Factors 2011-2016

Table United States Consumption Volume of Recombinant Coagulation Factors by Regions 2011-2016 (K Units)

Table United States Consumption Volume Market Share of Recombinant Coagulation Factors by Regions 2011-2016

Figure United States Consumption Volume Market Share of Recombinant Coagulation Factors by Regions in 2014

Figure United States Consumption Volume Market Share of Recombinant Coagulation Factors by Regions in 2015

Table United States Consumption Value of Recombinant Coagulation Factors by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Recombinant Coagulation Factors by Regions 2011-2016

Figure United States Consumption Value Market Share of Recombinant Coagulation Factors by Regions in 2014

Figure United States Consumption Value Market Share of Recombinant Coagulation Factors by Regions in 2015

Table Consumption Price of Recombinant Coagulation Factors by Regions 2011-2016 (USD/Unit)

Table United States and Major Manufacturers Capacity of Recombinant Coagulation Factors 2011-2016 (K Units)

Table United States Capacity Market Share of Major Recombinant Coagulation Factors Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Recombinant Coagulation Factors 2011-2016 (K Units)

Table United States Production Market Share of Major Recombinant Coagulation Factors Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Recombinant Coagulation Factors 2011-2016 (K Units)

Table United States Sales Market Share of Major Recombinant Coagulation Factors Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Recombinant Coagulation Factors 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Recombinant Coagulation Factors Manufacturers 2011-2016

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Recombinant Coagulation Factors 2011-2016

Figure United States Capacity Utilization Rate of Recombinant Coagulation Factors 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Recombinant Coagulation Factors 2011-2016

Figure United States Production Market Share of Major Recombinant Coagulation Factors Manufacturers in 2014

Figure United States Production Market Share of Major Recombinant Coagulation Factors Manufacturers in 2015

Figure United States Sales Market Share of Major Recombinant Coagulation Factors Manufacturers in 2014

Figure United States Sales Market Share of Major Recombinant Coagulation Factors Manufacturers in 2015

Figure United States Sales (K Units) and Growth Rate of Recombinant Coagulation Factors 2011-2016

Table United States Supply, Consumption and Gap of Recombinant Coagulation Factors 2011-2016 (K Units)

Table United States Import, Export and Consumption of Recombinant Coagulation Factors 2011-2016 (K Units)

Table Price of United States Recombinant Coagulation Factors Major Manufacturers 2011-2016 (USD/Unit)

Table Gross Margin of United States Recombinant Coagulation Factors Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Recombinant Coagulation Factors 2011-2016 (M USD)

Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Recombinant Coagulation Factors 2011-2016

Table Baxter International Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Baxter International Inc

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Baxter International Inc 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Baxter International Inc 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Baxter International Inc 2011-2016

Table Baxter International Inc Recombinant Coagulation Factors SWOT Analysis

Table Bayer AG Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Bayer AG

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer AG 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Bayer AG 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Bayer AG 2011-2016

Table Bayer AG Recombinant Coagulation Factors SWOT Analysis

Table Biogen Idec Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Biogen Idec

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen Idec 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Biogen Idec 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Biogen Idec 2011-2016

Table Biogen Idec Recombinant Coagulation Factors SWOT Analysis

Table CSL Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of CSL Ltd.

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CSL Ltd. 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of CSL Ltd. 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of CSL Ltd. 2011-2016

Table CSL Ltd. Recombinant Coagulation Factors SWOT Analysis

Table Grifols International SA Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Grifols International SA

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Grifols International SA 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Grifols International SA 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Grifols International SA 2011-2016

Table Grifols International SA Recombinant Coagulation Factors SWOT Analysis

Table Kedrion S.P.A. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Kedrion S.P.A.

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Kedrion S.P.A. 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Kedrion S.P.A. 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Kedrion S.P.A. 2011-2016

Table Kedrion S.P.A. Recombinant Coagulation Factors SWOT Analysis

Table Novo Nordisk A/S Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Novo Nordisk A/S

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk A/S 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Novo Nordisk A/S 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Novo Nordisk A/S 2011-2016

Table Novo Nordisk A/S Recombinant Coagulation Factors SWOT Analysis

Table Octapharma AG Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Octapharma AG

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Octapharma AG 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Octapharma AG 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Octapharma AG 2011-2016

Table Octapharma AG Recombinant Coagulation Factors SWOT Analysis

Table Pfizer Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Recombinant Coagulation Factors Picture and Specifications of Pfizer Inc.

Table Recombinant Coagulation Factors Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer Inc. 2011-2016

Figure Recombinant Coagulation Factors Capacity (K Units), Production (K Units) and Growth Rate of Pfizer Inc. 2011-2016

Figure Recombinant Coagulation Factors Production (K Units) and United States Market Share of Pfizer Inc. 2011-2016

Table Pfizer Inc. Recombinant Coagulation Factors SWOT Analysis

Table Recombinant Coagulation Factors Price by Regions 2011-2016

Table Recombinant Coagulation Factors Price by Product Types 2011-2016

Table Recombinant Coagulation Factors Price by Companies 2011-2016

Table Recombinant Coagulation Factors Gross Margin by Companies 2011-2016

Table Price Comparison of Recombinant Coagulation Factors by Regions 2011-2016 (USD/Unit)

Table Price of Different Recombinant Coagulation Factors Product Types (USD/Unit)

Table Market Share of Different Recombinant Coagulation Factors Price Level

Table Gross Margin of Different Recombinant Coagulation Factors Applications

Table Marketing Channels Status of Recombinant Coagulation Factors

Table Traders or Distributors of Recombinant Coagulation Factors with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Recombinant Coagulation Factors (USD/Unit) in 2015

Table United States Import, Export, and Trade of Recombinant Coagulation Factors (K Units)

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Recombinant Coagulation Factors 2016-2021

Figure United States Capacity Utilization Rate of Recombinant Coagulation Factors 2016-2021

Table United States Recombinant Coagulation Factors Production by Type 2016-2021 (K Units)

Table United States Recombinant Coagulation Factors Production Market Share by Type 2016-2021

Figure United States Production Market Share of Recombinant Coagulation Factors by Type in 2021

Figure United States Sales (K Units) and Growth Rate of Recombinant Coagulation Factors 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Recombinant Coagulation Factors 2016-2021

Figure United States Sales of Recombinant Coagulation Factors by Applications 2016-2021 (K Units)

Table United States Production Market Share of Recombinant Coagulation Factors by Applications 2016-2021

Figure United States Production Market Share of Recombinant Coagulation Factors by Applications in 2021

Table United States Production, Import, Export and Consumption of Recombinant Coagulation Factors 2016-2021 (K Units)

Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Recombinant Coagulation Factors 2016-2021

Table Major Raw Materials Suppliers of Recombinant Coagulation Factors with Contact Information

Table Manufacturing Equipment Suppliers of Recombinant Coagulation Factors with Contact Information

Table Major Players of Recombinant Coagulation Factors with Contact Information

Table Key Consumers of Recombinant Coagulation Factors with Contact Information

Table Supply Chain Relationship Analysis of Recombinant Coagulation Factors

Table New Project SWOT Analysis of Recombinant Coagulation Factors

Table New Project Investment Feasibility Analysis of Recombinant Coagulation Factors

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370